Looking to block out the sun and add a stylish touch to your home? In this Home Zone project, we’re tackling window coverings ...

A clever new set of glasses may offer new hope to people with macular degeneration. By copying the structure of a fly's eyes, ...

Johnson & Johnson has agreed to acquire Intra-Cellular Therapies for approximately $14.6 billion, in the largest biopharma merger-and-acquisition (M&A) deal announced in two years.

As the cold winter weather sets in, keeping your home warm and energy-efficient becomes a top priority. One of the biggest ...

It offers a variety of products, including faux wood, cellular, mini, vertical, vinyl and wood blinds. Shades are also available in cellular, roller, Roman, simply sheer, soft Roman and woven wood ...

Intra-Cellular recently guided to at least $5 billion in peak Caplyta sales. Intra-Cellular’s stock was trading at $127.48, up $32.61, or 34%. J&J’s stock (NYSE:JNJ) was selling for $143.39, up $1.34.

Acquisition includes CAPLYTA® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and ...

We've completed our trek across the vast halls of CES 2025 to round up the best smart home devices for Apple users. From ...

Aaron Thompson, 29, appeared for a sentencing hearing in front of Judge Brian Telander Friday, where the state asked for the maximum penalty of 45 years.

The key processes of skin aging are now being understood in sufficient detail that targeted prescription therapies for ...

A striking vehicle designed to carry you into tomorrow, and the perfect playlist to accompany you while you're in it.

Activation of SIGMAR1 is expected to restore cellular homeostasis by inducing autophagy, which may slow neurodegeneration in patients with early AD.